Top-News
Biotechnologie USA

Pliant Therapeutics Inc Aktie

Aktie
WKN:  A2P4YV ISIN:  US7291391057 US-Symbol:  PLRX
1,66 $
+0,045 $
+2,79%
1,4659 € 17:41:14 Uhr
Depot/Watchlist
Aktienanzahl *
60,85 Mio.
Marktkapitalisierung *
85,13 Mio. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 13.02.2025

Pliant Therapeutics Inc News

28.03.25 - PR Newswire
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics PR Newswire
13.03.25 - PR Newswire
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics PR Newswire
04.03.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pliant Therapeutics, Inc- PLRX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pliant Therapeutics, Inc- PLRX PR Newswire
03.03.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pliant Therapeutics, Inc. - PLRX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pliant Therapeutics, Inc. - PLRX PR Newswire
25.02.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pliant Therapeutics, Inc. - PLRX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pliant Therapeutics, Inc. - PLRX PR Newswire
20.02.25 - PR Newswire
PLRX Investors Have Opportunity to Join Pliant Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
PLRX Investors Have Opportunity to Join Pliant Therapeutics, Inc. Fraud Investigation with the Schall Law Firm PR Newswire
18.02.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pliant Therapeutics, Inc. - PLRX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pliant Therapeutics, Inc. - PLRX PR Newswire
26.09.23 - PR Newswire
Thinking about buying stock in Pliant Therapeutics, Esperion Therapeutics, Murphy Canyon Acquisition Corp, Limbach Holdings, or Vaccitech?
Thinking about buying stock in Pliant Therapeutics, Esperion Therapeutics, Murphy Canyon Acquisition Corp, Limbach Holdings, or Vaccitech? PR Newswire
11.07.22 - PR Newswire
Thinking about buying stock in Pliant Therapeutics, Phunware, RedHill Biopharma, Seelos Therapeutics, or HTG Molecular Diagnostics?
Thinking about buying stock in Pliant Therapeutics, Phunware, RedHill Biopharma, Seelos Therapeutics, or HTG Molecular Diagnostics? PR Newswire
07.09.21 - PR Newswire
Thinking about buying stock in Pliant Therapeutics, Comstock Mining, Metromile, Progenity, or Paya Holdings?
Thinking about buying stock in Pliant Therapeutics, Comstock Mining, Metromile, Progenity, or Paya Holdings? PR Newswire

Newssuche

Videos

newspaper
30.04.25 +13,48%
Technical Trading: Cotton Long Chance
Cotton Long Typ: Turbo Open End WKN: VP6N8D Hebel: 3,80 Laufzeit: OpenEnd Einstieg: Market ... Mehr »